I agree that this site is using cookies. You can find further informations here.
X
Bakanay, Şule Mine
46  results:
Search for persons X
?
1

Prognostic Value of the Expression of Receptor Tyrosine Kin..:

Yikilmaz, Aysun Şentürk ; Bakanay, Şule Mine ; Nurdan Avcı, Duygu...
International Journal of Hematology-Oncology and Stem Cell Research.  , 2023
Link: https://doi.org/10.18502..
 
?
2

P-132 Post-induction undetectable flow minimal residual dis..:

Seval, Guldane Cengiz ; Dalva, Klara ; Bakanay, Sule Mine...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S108 , 2023
Link: https://doi.org/10.1016/..
 
?
3

Leukemia: Reduction Ratio and Halving Time of BCR: : ABL1 I..:

Ceran, Funda ; Akıncı, Sema ; Uçar, Mehmet Ali...
Turkish Journal of Hematology.  39 (2022)  3 - p. 196-203 , 2022
Link: https://doi.org/10.4274/..
 
?
4

Predictive Factors for Molecular Response in Chronic Myeloi..:

Ceran, Funda ; Akıncı, Sema ; Uçar, Mehmet Ali...
Turkish Journal of Hematology.  , 2022
Link: https://doi.org/10.4274/..
 
?
5

A Rare Lymphoproliferative Disease: Castleman Disease:

Gündüz, Eren ; Özdemir, Nihal ; Bakanay, Şule Mine.
Turkish Journal of Hematology.  , 2021
Link: https://doi.org/10.4274/..
 
?
6

The Triple Positivity for EBV, PD-1, and PD-L1 Identifies a..:

Ozturk, Vedia ; Yikilmaz, Aysun Senturk ; Kilicarslan, Aydan...
Clinical Lymphoma Myeloma and Leukemia.  20 (2020)  7 - p. e375-e381 , 2020
Link: https://doi.org/10.1016/..
 
?
7

Thiol-disulphide homeostasis in essential thrombocythemia p..:

Yıkılmaz, Aysun Şentürk ; Bakanay, Şule Mine ; Akinci, Sema...
Journal of Medical Biochemistry.  38 (2019)  4 - p. 475-480 , 2019
Link: https://doi.org/10.2478/..
 
?
8

Is Cd11c and Fmc7 Negativity in Chronic Lymphocytic Leukemi..:

Şentürk Yikilmaz, Aysun ; Akinci, Sema ; Bakanay, Şule Mine..
Indian Journal of Hematology and Blood Transfusion.  36 (2019)  1 - p. 84-90 , 2019
Link: https://doi.org/10.1007/..
 
?
9

Lupus-like symptoms with anti-RNP/Sm and anti-nuclear antib..:

Maral, Senem ; Bakanay, Sule Mine ; Kucuksahin, Orhan.
Journal of Oncology Pharmacy Practice.  26 (2019)  3 - p. 738-741 , 2019
Link: https://doi.org/10.1177/..
 
?
10

Epstein-Barr Virus-Negative Post-Transplant Lymphoprolifera..:

Bakanay, Şule Mine ; Kaygusuz, Gülşah ; Topçuoğlu, Pervin...
Turkish Journal of Hematology.  31 (2014)  1 - p. 79-83 , 2014
Link: https://doi.org/10.4274/..
 
?
11

Chemosensitivity to Induction or High Dose Therapy, Pre/Pos..:

Bakanay, Sule Mine ; Dalva, Klara ; Koksoy, Elif Berna...
Biology of Blood and Marrow Transplantation.  20 (2014)  2 - p. S105-S106 , 2014
Link: https://doi.org/10.1016/..
 
?
12

Blood group genotyping in multi-transfused patients:

Bakanay, Sule Mine ; Ozturk, Aysenur ; Ileri, Talia...
Transfusion and Apheresis Science.  48 (2013)  2 - p. 257-261 , 2013
Link: https://doi.org/10.1016/..
 
?
13

Myeloma as a Second Malignancy following AML: Is a Second A..:

Bakanay, Sule Mine ; Serbest, Esin ; Dalva, Klara..
Case Reports in Medicine.  2012 (2012)  - p. 1-3 , 2012
Link: https://doi.org/10.1155/..
 
?
14

Does continuous flow apheresis influence viability in allog..:

Bakanay, Sule Mine ; Dalva, Klara ; Arat, Mutlu...
Transfusion and Apheresis Science.  34 (2006)  2 - p. 171-178 , 2006
Link: https://doi.org/10.1016/..
 
?
15

P-038: Postinduction minimal residual disease (MRD) within ..:

Seval, Guldane Cengiz ; Dalva, Klara ; Öz, Memnune Dilek...
Clinical Lymphoma Myeloma and Leukemia.  21 (2021)  - p. S59 , 2021
Link: https://doi.org/10.1016/..
 
1-15